Browse > Article
http://dx.doi.org/10.1055/s-0042-1751027

Extracorporeal Shock Wave Therapy for Hypertrophic Scars  

Chuangsuwanich, Apirag (Division of Plastic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University)
Kongkunnavat, Natthapong (Division of Plastic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University)
Kamanamool, Malika (Division of Plastic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University)
Maipeng, Gulradar (Perioperative Nurse Division, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University)
Kamanamool, Nanticha (Department of Preventive and Social Medicine, Faculty of Medicine Srinakharinwirot University)
Tonaree, Warangkana (Division of Plastic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University)
Publication Information
Archives of Plastic Surgery / v.49, no.4, 2022 , pp. 554-560 More about this Journal
Abstract
Background Hypertrophic scars cause aesthetic concerns and negatively affect the quality of life. A gold standard treatment for hypertrophic scars has not been established due to various responses of modalities. Extracorporeal shock wave therapy (ESWT) is a noninvasive and affects scar remodeling by fibroblast regulation. This study investigated the effectiveness of ESWT for hypertrophic scars. Methods Twenty-nine patients were enrolled. All patients underwent ESWT once a week for 6 consecutive weeks. Their scars were assessed using the Patient and Observer Scar Assessment Scale (POSAS), erythema index, melanin index, and scar pliability before treatment and again 4 weeks after treatment completion. Results Thirty-four hypertrophic scars in this study had persisted for between 6 months and 30 years. Most scars developed after surgical incision (55.88%). The chest and upper extremities were the predominant areas of occurrence (35.29% each). Most of the POSAS subscales and total scores were significantly improved 4 weeks after treatment (p < 0.05). Furthermore, the pain, itching, and pigmentation subscale were improved. The pliability, melanin index, and erythema index were also improved, but without significance. The patients were satisfied with the results and symptoms alleviation, although subjective score changes were insignificant. No serious adverse events were found. The patients reported pruritus in 62.5% and good pain tolerance in 37.5%. Subgroup analyses found no differences in scar etiologies or properties at different parts of the body. Conclusion The ESWT is a modality for hypertrophic scar treatment with promising results. Most of POSAS subscales were significantly improved.
Keywords
extracorporeal shock wave; hypertrophic scar; wound healing; scar prevention;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Mittermayr R, Antonic V, Hartinger J, et al. Extracorporeal shock wave therapy (ESWT) for wound healing: technology, mechanisms, and clinical efficacy. Wound Repair Regen 2012;20(04):456-465
2 van Zuijlen PP, Angeles AP, Kreis RW, Bos KE, Middelkoop E. Scar assessment tools: implications for current research. Plast Reconstr Surg 2002;109(03):1108-1122   DOI
3 Draaijers LJ, Botman YA, Tempelman FR, Kreis RW, Middelkoop E, van Zuijlen PP. Skin elasticity meter or subjective evaluation in scars: a reliability assessment. Burns 2004;30(02):109-114   DOI
4 Neto P, Ferreira M, Bahia F, Costa P. Improvement of the methods for skin mechanical properties evaluation through correlation between different techniques and factor analysis. Skin Res Technol 2013;19(04):405-416
5 Qureshi AA, Ross KM, Ogawa R, Orgill DP. Shock wave therapy in wound healing. Plast Reconstr Surg 2011;128(06):721e-727e   DOI
6 d'Agostino MC, Craig K, Tibalt E, Respizzi S. Shock wave as biological therapeutic tool: from mechanical stimulation to recovery and healing, through mechanotransduction. Int J Surg 2015;24(Pt B):147-153   DOI
7 Draaijers LJ, Tempelman FR, Botman YA, et al. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg 2004;113(07):1960-1965   DOI
8 Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011;17(1-2):113-125   DOI
9 Lorenz P, Bari AS. Scar prevention, treatment, and revision. In: Neligan PC, ed. Plastic Surgery 3rd ed. London: Elsevier Saunders; 2012:297-318
10 Holfeld J, Tepekoylu C, Kozaryn R, et al. Shockwave therapy differentially stimulates endothelial cells: implications on the control of inflammation via toll-like receptor 3. Inflammation 2014;37(01):65-70   DOI
11 Durani P, McGrouther DA, Ferguson MW. Current scales for assessing human scarring: a review. J Plast Reconstr Aesthet Surg 2009;62(06):713-720   DOI
12 Fearmonti R, Bond J, Erdmann D, Levinson H. A review of scar scales and scar measuring devices. Eplasty 2010;10:e43
13 Antonic V, Mittermayr R, Schaden W, Stojadinovic A. Evidence supporting extracorporeal shock wave therapy for acute and chronic soft tissue wounds. Wounds 2011;23(07):204-215
14 Li H, Liu ML. Cardiac shock wave therapy: an alternative noninvasive therapy for refractory angina. Eur Rev Med Pharmacol Sci 2018;22(16):5402-5410
15 Fioramonti P, Cigna E, Onesti MG, Fino P, Fallico N, Scuderi N. Extracorporeal shock wave therapy for the management of burn scars. Dermatol Surg 2012;38(05):778-782   DOI
16 Cui HS, Joo SY, Cho YS, et al. Effect of extracorporeal shock wave therapy on keratinocytes derived from human hypertrophic scars. Sci Rep 2021;11(01):17296   DOI
17 Ito K, Fukumoto Y, Shimokawa H. Extracorporeal shock wave therapy for ischemic cardiovascular disorders. Am J Cardiovasc Drugs 2011;11(05):295-302   DOI
18 Sukubo NG, Tibalt E, Respizzi S, Locati M, d'Agostino MC. Effect of shock waves on macrophages: a possible role in tissue regeneration and remodeling. Int J Surg 2015;24(Pt B):124-130   DOI
19 Frairia R, Berta L. Biological effects of extracorporeal shock waves on fibroblasts. A review. Muscles Ligaments Tendons J 2012;1(04):138-147
20 Ogawa R. Mechanobiology of scarring. Wound Repair Regen 2011;19(Suppl 1):s2-s9   DOI
21 Wang JH, Thampatty BP, Lin JS, Im HJ. Mechanoregulation of gene expression in fibroblasts. Gene 2007;391(1-2):1-15   DOI
22 Moortgat P, Anthonissen M, Van Daele U, et al. The effects of shock wave therapy applied on hypertrophic burn scars: a randomised controlled trial. Scars Burn Heal 2020;6:2059513120975624
23 Wang CJ, Ko JY, Chou WY, Cheng JH, Kuo YR. Extracorporeal shockwave therapy for treatment of keloid scars. Wound Repair Regen 2018;26(01):69-76   DOI
24 Wang W, Liu H, Song M, Fang W, Yuan F. Clinical effect of cardiac shock wave therapy on myocardial ischemia in patients with ischemic heart failure. J Cardiovasc Pharmacol Ther 2016;21(04):381-387   DOI
25 Nicholas RS, Falvey H, Lemonas P, et al. Patient-related keloid scar assessment and outcome measures. Plast Reconstr Surg 2012;129(03):648-656   DOI
26 Speed C. A systematic review of shockwave therapies in soft tissue conditions: focusing on the evidence. Br J Sports Med 2014;48(21):1538-1542   DOI
27 Pinheiro NM, Melo PR, Crema VO, Mendonca AC. Effects of radio-frequency procedure on hypertrophic scar due to burns. J Eur Acad Dermatol Venereol 2015;29(01):187-189   DOI
28 Romeo P, Lavanga V, Pagani D, Sansone V. Extracorporeal shock wave therapy in musculoskeletal disorders: a review. Med Princ Pract 2014;23(01):7-13   DOI
29 Verhaegen PDHM, van der Wal MBA, Middelkoop E, van Zuijlen PPM. Objective scar assessment tools: a clinimetric appraisal. Plast Reconstr Surg 2011;127(04):1561-1570   DOI
30 Joo SY, Lee SY, Cho YS, Seo CH. Clinical utility of extracorporeal shock wave therapy on hypertrophic scars of the hand caused by burn injury: a prospective, randomized, double-blinded study. J Clin Med 2020;9(05):E1376
31 Rabello FB, Souza CD, Farina Junior JA. Update on hypertrophic scar treatment. Clinics (Sao Paulo) 2014;69(08):565-573   DOI
32 Durani P, McGrouther DA, Ferguson MW. The Patient Scar Assessment Questionnaire: a reliable and valid patient-reported outcomes measure for linear scars. Plast Reconstr Surg 2009;123(05):1481-1489   DOI
33 Cui HS, Hong AR, Kim JB, et al. Extracorporeal shock wave therapy alters the expression of fibrosis-related molecules in fibroblast derived from human hypertrophic scar. Int J Mol Sci 2018;19(01):E124
34 Gollmann-Tepekoylu C, Nagele F, Graber M, et al. Shock waves promote spinal cord repair via TLR3. JCI Insight 2020;5(15):134552